| ACE | angiotensin-converting enzyme |
| AGA | appropriate for gestational age |
| Ang | angiotensin |
| AT-1 | angiotensin II type 1 |
| AT-2 | angiotensin II type 2 |
| AVA | arterio–venous anastomosis |
| CA | carbonic anhydrous |
| DVM | delayed villous maturation |
| ET-1 | endothelin-1 |
| FD | fetal demise |
| FC | fold changes |
| FGR | fetal growth restriction |
| FLP | fetoscopic laser photocoagulation |
| FTV | fetal thrombotic vasculopathy |
| HIF-1α | hypoxia inducible factor 1α |
| HMOX1 | heme oxygenase 1 |
| IGF | insulin-like growth factor |
| IRI | ischemia-reperfusion injury |
| LC3 | light chain 3 |
| MC | monochorionic |
| MCA-PSV | middle cerebral artery peak systolic value |
| MDA | malondialdehyde |
| mtDNA | mitochondrial DNA |
| NFE2L2 | nuclear factor erythroid 2 like 2 |
| OS | oxidative stress |
| PE | preeclampsia |
| PlGF | placental growth factor |
| RAS | renin–angiotensin system |
| RI | resistance index |
| ROS | reactive oxygen species |
| sENG | soluble endoglin |
| sFGR | selective fetal growth restriction |
| sFlt1 | soluble fms-like tyrosine kinase 1 |
| StO2% | tissue venous oxygenation |
| TAPS | twin anemia-polycythemia sequence |
| TTTS | twin-to-twin transfusion syndrome |
| VEGF | vascular endothelial growth factor |
| Δ | delta |